SCHEMBL2854679

SCHEMBL2854679

CC(C)(C)OC(=O)N1C[C@@H](N2CCC(n3cnc4cc(C(F)(F)F)ccc43)CC2)C[C@H]1C(=O)N1CCSC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 0.43
USP2 O75604 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 2/20 0.42
HTT P42858 2/20 0.42
POLB P06746 1/20 0.42
MAPK10 P53779 1/20 0.42
PREP P48147 1/20 0.37
ALDH1A1 P00352 3/20 0.36
PKM P14618 2/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HCAR1 Q9BXC0 1/20 0.36
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MCHR1 Q99705 1/20 0.33
IDO1 P14902 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2849722 0.88 USP2 (0.51) DPP4USP2SMN1; SMN2GAAHTT
SCHEMBL2708669 0.84 DPP4 (0.47) DPP4USP2SMN1; SMN2LMNAPREP
SCHEMBL2711568 0.83 DPP4 (0.40) DPP4USP2LMNAPREPPKM
SCHEMBL2711239 0.82 DPP4 (0.40) DPP4USP2LMNAPREPPKM
SCHEMBL2709714 0.82 DPP4 (0.66) DPP4PREPNPSR1DPP8DPP9
SCHEMBL2711201 0.81 ALDH1A1 (0.43) DPP4HTTPREPALDH1A1
SCHEMBL2710558 0.81 DPP4 (0.61) DPP4SMN1; SMN2LMNAPOLBALDH1A1
SCHEMBL2709616 0.80 DPP4 (0.59) DPP4PREPDPP8DPP9
SCHEMBL2708514 0.79 PREP (0.40) DPP4PREP
SCHEMBL2709994 0.79 DPP4 (0.46) DPP4LMNAHTTDPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790725-B2 Thiazolidine derivatives and medicinal use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-09-07 US disclosed
US-20070259880-A1 THIAZOLIDINE DERIVATIVES AND MEDICINAL USE THEREOF MITSUBISHI PHARMA CORPORATION (JP) 2007-11-08 US disclosed
US-20040259883-A1 Thiazolidine derivative and medicinal use thereof MITSUBISHI PHARMA CORPORATION (JP) 2004-12-23 US disclosed
EP-1426366-A1 THIAZOLIDINE DERIVATIVE AND MEDICINAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259880-A1 THIAZOLIDINE DERIVATIVES AND MEDICINAL USE THEREOF DPP4, DPP7, DPP3 DPP4 1/4885USP2 3903/4885SMN1; SMN2 3494/4885
US-20040259883-A1 Thiazolidine derivative and medicinal use thereof DPP4, DPP7, DPP3 DPP4 1/4885USP2 3799/4885SMN1; SMN2 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.